mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.04 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.04 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.05 |
mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.05 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.05 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.05 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.05 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.05 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.05 |